CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data Non-obstructive High-Risk Plaques Increase the Risk of Future Culprit Lesions Comparable to Obstructive Plaques Without High-Risk Features: The ICONIC Study Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women Comprehensive Investigation of Circulating Biomarkers and their Causal Role in Atherosclerosis-related Risk Factors and Clinical Events Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Original ResearchVolume 73, Issue 22, June 2019

JOURNAL:J Am Coll Cardiol. Article Link

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

DL Bhatt, G Steg, and on behalf of the REDUCE-IT Investigators. Keywords: eicosapentaenoic acid; icosapent ethyl; statin; time-to-first-event;

ABSTRACT